Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
For the nine months ended September 30, 2026, Stoke Therapeutics reported a net loss of $185.3 million, a significant reversal from a net income of $51.0 million in the prior year period, primarily due to a sharp decrease in revenue from $183.0 million to $26.8 million. Operating expenses rose substantially, with research and development costs increasing by 55% to $149.0 million as the company advances its clinical programs for zorevunersen.
Ocean Power Technologies Debt Financing Update with Vanquish Funding Group Inc.
Ocean Power Technologies entered into a Securities Purchase Agreement with Vanquish Funding Group for a 12% promissory note in the principal amount of $373,750. The agreement includes potential additional tranches of financing up to $2.875 million over the next twelve months and allows for conversion into common stock only upon an event of default.
BWX Technologies $1.25B Debt Financing with Wells Fargo Bank, National Association
BWX Technologies entered into an amendment to its existing credit agreement to extend the maturity of its $1.25 billion senior secured revolving credit facility by one year to November 10, 2031. The amendment also modifies the minimum interest coverage ratio requirements and introduces a new pricing grid tied to the company's corporate credit ratings.
For the nine months ended September 30, 2026, SLR Private Credit BDC II LLC reported total investment income of $3.79 million and net investment income of $1.49 million. The company's net asset value per unit increased to $16.37 from $16.01 at the end of 2025, while total unitholders' capital grew to $19.54 million despite $0.8 million in distributions.
For the nine months ended September 30, 2026, Ardelyx reported total revenues of $343.0 million, a significant increase from $282.1 million in the prior year period, driven primarily by net product sales of IBSRELA and XPHOZAH. Despite the revenue growth, the company recorded a net loss of $55.1 million for the first nine months of 2026, though this was an improvement over the $61.2 million net loss in the same period of 2025.
PennantPark Floating Rate Capital Ltd. declared a monthly distribution for November 2026 of $0.0833 per share. The distribution consists of an $0.08 base dividend and a $0.0033 supplemental dividend, payable on December 1, 2026, to stockholders of record as of November 13, 2026.
Nextera Energy EVP, Finance & CFO Michael Dunne Sells $585K of Stock
Michael Dunne, EVP, Finance & CFO, sold 6,888 shares of Nextera Energy Inc at $85.00 a share, worth $585K in total on Nov 2, 2026. Shares held after the trade: 64,063 (-9.7%).
SCP Private Credit Income BDC LLC reported a net increase in unitholders' capital resulting from operations of $2.6 million for the nine months ended September 30, 2026, down from $7.0 million in the prior year period. The company's net asset value per unit decreased to $9.01 from $9.42 at the end of 2025, primarily driven by net unrealized losses on investments and distributions to unitholders.
Profound Medical Partnership with Cook Medical Holdings LLC
Profound Medical entered into a supply and distribution agreement with Cook Medical to appoint them as a non-exclusive distributor of the TULSA-PRO system in the U.S. The partnership integrates TULSA-PRO into Cook's Copernicus program for intraoperative MRI suites, expanding Profound's sales channels while retaining direct recurring revenue from disposables and service.
Fathom Holdings Debt Financing Update with two accredited investors
Fathom Holdings entered into a Third Omnibus Amendment to its Senior Secured Convertible Promissory Notes, extending the maturity date from November 1, 2026, to November 30, 2026. The amendment defers all accrued and unpaid interest until the new maturity date and introduces a weekly extension fee of 0.5% of the outstanding principal amount.
For the nine months ended September 30, 2026, SLR HC BDC LLC reported total investment income of $7.1 million and net investment income of $3.1 million. The company's net asset value per unit decreased slightly to $20.87 from $21.11 at the end of 2025, while total unitholders' capital grew to $60.7 million due to $16.7 million in capital contributions.
RxSight reported Q3 2026 revenue of $24.6 million, a 19% decrease year-over-year, primarily due to competitive pressures. The company highlighted a strengthened commercial leadership team and a $60 million cash infusion from its strategic collaboration with Alcon, ending the quarter with $254.7 million in cash and investments.
Term
3 months
“Since I joined last quarter, the team has moved quickly and accomplished a great deal in a short period of time. We have strengthened our commercial organization and leadership, made progress across key long-term growth initiatives, and taken decisive actions to align our cost structure with our priorities. While there is more work ahead, we remain focused on execution. Based on our progress, I am confident we are positioning our company for long-term success.”
Aziz Mottiwala, President and Chief Executive Officer
Sixth Street Specialty Lending reported third quarter 2026 financial results with net investment income of $0.44 per share and a net asset value of $16.19 per share. The company also declared a fourth quarter base dividend of $0.42 per share and a third quarter supplemental dividend of $0.01 per share.
“Our objective is not to compete for the same investments on the same terms, but to bring a differentiated perspective to where and how we invest capital. We believe these capabilities position us well to navigate an increasingly bifurcated market and compound long-term value for our shareholders.”
Artiva Biotherapeutics COO, CLO, Compliance Officer Jennifer Bush Sells $35.3K of Stock
Jennifer Bush, COO, CLO, Compliance Officer, sold 8,439 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $35.3K in total on Nov 2, 2026. Shares held after the trade: 357,720 (-2.3%).
PennantPark Investment Corporation declared a monthly distribution for November 2026 of $0.08 per share. The distribution consists of a $0.04 base dividend and a $0.04 supplemental dividend, payable on December 1, 2026, to stockholders of record as of November 13, 2026.
Regis Corporation held its 2026 Annual Meeting where five of six director nominees failed to receive a majority of votes cast, triggering conditional resignation offers under the company's majority voting policy. Shareholders also voted against the advisory 'say-on-pay' proposal regarding executive compensation, while ratifying Grant Thornton LLP as the independent auditor. Separately, the company announced that Jamie Suarez, EVP of Company Operations, will depart the company effective October 30, 2026.
Timothy G. NeCastro retired as President and CEO effective November 2, 2026, which was an acceleration of his previously announced retirement date. Brian W. Bolash, the company's Executive Vice President, has been appointed Interim President and CEO effective November 3, 2026, while the board continues its search for a permanent successor.
Weyco Group's Board of Directors declared a special cash dividend of $2.00 per share, representing a total cash outlay of approximately $19 million. The dividend is payable on January 8, 2027, to shareholders of record as of November 17, 2026, and is being funded by excess cash on the company's balance sheet.
MarineMax announced that all regulatory approvals and clearances have been obtained for its pending merger with affiliates of Safe Harbor Marinas (a Blackstone portfolio company). The company expects the transaction to close by the end of 2026, subject to a shareholder vote scheduled for November 11, 2026.
Real Remax Group M&A Deal with RE/MAX Holdings, Inc.
Real REMAX Group Inc. filed an amendment to its 8-K to provide historical and pro forma financial statements following its completed acquisition of RE/MAX Holdings, Inc. and The Real Brokerage Inc. The transaction, which closed on August 24, 2026, was accounted for as a business combination with Real as the accounting acquiror. The filing also details a $550 million term loan facility and a $40 million revolving credit facility used to finance the combination.
Regeneron Pharmaceuticals Insider Michael S. Brown Sells $1.69M of Stock
Michael S. Brown sold 1,929 shares of Regeneron Pharmaceuticals, Inc. at $875.00 a share, worth $1.69M in total on Oct 30, 2026. Shares held after the trade: 1,380 (-58.3%).
Financial Institutions Director Andrew W. Dorn Jr. Buys $63.2K of Stock
Andrew W. Dorn Jr., Director, bought 1,575 shares of Financial Institutions Inc at $40.11 a share, worth $63.2K in total on Nov 2, 2026. Shares held after the trade: 40,641 (+4.0%).
Braemar Hotels & Resorts Divestiture to Evergreen Acquisitions, LLC for $372M
Braemar Hotels & Resorts completed the sale of the 210-room Four Seasons Resort Scottsdale to Evergreen Acquisitions, LLC for $372 million in cash. The company expects to use the proceeds to fund remaining fees related to its transition to a self-managed REIT, which is on track for completion in mid-November 2026.
Acuity Inc. (De) President & CEO Neil Ashe Sells $4.23M of Stock
Neil Ashe, President & CEO, sold 13,217 shares of Acuity Inc. (De) at $313.98 to $325.07 a share (average $320.20) in 13 transactions, worth $4.23M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 64,858 (-1.5%).
Skyworks Solutions reported Q4 fiscal 2026 standalone revenue of $1.046 billion and non-GAAP diluted EPS of $1.28. The company highlighted the completion of its combination with Qorvo, which closed after the quarter end, creating a full-stack RF front-end platform targeting $500 million in annual cost synergies. For the full fiscal year 2026, Skyworks reported revenue of $3.96 billion.
“Combining with Qorvo gives us the scale and the technology breadth to lead the next era of wireless, as AI moves from the infrastructure to the devices, vehicles and machines around us.”
Phil Brace, chief executive officer and president of Skyworks
“Because our combination with Qorvo closed after the end of our fiscal fourth quarter, our reported September-quarter results are Skyworks standalone.”
Philip Carter, chief financial officer and senior vice president of Skyworks
Arvinas, Inc. reported total assets of $607.5 million as of September 30, 2026, a decrease from $717.9 million at the end of 2025, primarily driven by a reduction in marketable securities and the recognition of deferred revenue. The company maintains a cash runway expected to fund operations into the second half of 2028, focusing on clinical advancements for candidates like ARV-393 and ARV-027.
Artiva Biotherapeutics CEO Fred Aslan Sells $260K of Stock
Fred Aslan, CEO, sold 62,178 shares of Artiva Biotherapeutics, Inc. at $4.18 a share, worth $260K in total on Nov 2, 2026. Shares held after the trade: 1,457,428 (-4.1%).
Vertex Pharmaceuticals reported total revenues of $3.44 billion for the third quarter of 2026, a 12% increase compared to the same period in 2025. Net income for the quarter was $653.6 million, down from $1.08 billion in the prior year, primarily driven by significantly higher operating expenses and a $9.06 billion acquisition of Crinetics Pharmaceuticals.
Sotera Health reported a significant increase in net income for the nine months ended September 30, 2026, reaching $138.6 million compared to $43.1 million in the prior year period. This growth was driven by higher service revenues and the absence of the $64.9 million Illinois EO litigation settlement charge that impacted 2025 results.
Transcat Inc. reported total revenue of $97.1 million for the second quarter ended September 26, 2026, an 18% increase year-over-year, driven primarily by strong growth in Service revenue. Despite the revenue growth, net income for the six-month period decreased to $3.7 million from $4.5 million in the prior year, impacted by higher operating expenses and interest costs.